Article

A real-world intention-to-treat analysis of a decade’s experience of treatment of hepatitis C with interferon-based therapies

2016-08-24

Abstract excerpt

<h4>Objectives: </h4> To assess the uptake of pegylated interferon (PegIFN) plus ribavirin (RBV)-based regimens in patients with hepatitis C virus (HCV) in a large, single-centre, real-world setting over 10 years. <h4>Methods: </h4>: This was a single centre, retrospective analysis of data from patients who attended their first appointment for treatment of HCV genotype 1–3 between 2003 and 2013. Patients were str...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a6a1fa14-84c3-516d-8ac2-9bc4ba146def
DOI: 10.12688/f1000research.9114.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A real-world intention-to-treat analysis of a decade’s experience of treatment of hepatitis C with interferon-based therapiesDOI 10.12688/f1000research.9114.1Read

Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study.Semantic proximity Read

Hepatitis C infection: eligibility for antiviral therapies.Semantic proximity Read

Clinical outcomes in a cohort of anti-hepatitis C virus-positive patients with significant barriers to treatment referred to a Norwegian outpatient clinic.Semantic proximity Read

Real-world use, effectiveness and safety of anti-viral treatment in chronic hepatitis C genotype 3 infection.Semantic proximity Read

Current treatment status and barriers for patients with chronic HCV infection in mainland China: A national multicenter cross-sectional survey in 56 hospitals.Semantic proximity Read

Pegylated interferon-α2a plus ribavirin for chronic hepatitis C in a real-life setting: the Hepatys French cohort (2003-2007).Semantic proximity Read

Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV eliminationSemantic proximity Read

Costs and outcomes of treating chronic hepatitis C patients in routine care - results from a nationwide multicenter trial.Semantic proximity Read

Final Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era.Semantic proximity Read

Hepatitis C treatment at three Norwegian hospitals 2000-2011.Semantic proximity Read

"Fighting an uphill battle": experience with the HCV triple therapy: a qualitative thematic analysis.Semantic proximity Read

Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety.Semantic proximity Read